Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q1FY24 of ₹1,021.00 Crores up from ₹951.00 Crore year on year, a rise of 7.36%.
Total Expenses for Q1FY24 of ₹784.00 Crores up from ₹762.00 Crores year on year, a rise of 2.89%.
Consolidated Net Profit of ₹208.00 Crores up 18.86% from ₹175.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹16.24, up 19.15% from ₹13.63 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.